- All sections
- C - Chemistrymetallurgy
- C07J - Steroids
- C07J 63/00 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
Patent holdings for IPC class C07J 63/00
Total number of patents in this class: 495
10-year publication summary
26
|
53
|
36
|
34
|
43
|
32
|
35
|
35
|
25
|
12
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Reata Pharmaceuticals, Inc. | 121 |
38 |
Reata Pharmaceuticals Holdings, LLC | 47 |
21 |
Sage Therapeutics, Inc. | 350 |
17 |
ViiV Healthcare UK (no.5) Limited | 84 |
13 |
Hetero Labs Limited | 44 |
12 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 813 |
11 |
Bristol-myers Squibb Company | 4848 |
9 |
Ardelyx, Inc. | 113 |
9 |
Glaxosmithkline LLC | 538 |
7 |
Glaxosmithkline Biologicals S.A. | 1631 |
6 |
Adjuvance Technologies, Inc., AKA Adjuvance | 22 |
6 |
Daiichi Sankyo Company, Limited | 1852 |
6 |
Memorial Sloan-Kettering Cancer Center | 1889 |
6 |
Pacific Arrow Limited | 14 |
6 |
ViiV Healthcare UK (No. 4) Limited | 22 |
6 |
ViiV Healthcare UK (No. 5) Limited | 46 |
6 |
Glaxosmithkline Intellectual Property (no.2) Limited | 282 |
5 |
The General Hospital Corporation | 4679 |
5 |
Valtion Teknillinen Tutkimuskeskus | 156 |
5 |
President and Fellows of Harvard College | 5908 |
4 |
Other owners | 297 |